title: Prospective investigation of second-trimester thrombin activation and preterm birth.
abstract: OBJECTIVE
  We sought to determine if second-trimester amniotic fluid thrombin-antithrombin (TAT) complexes concentration correlates with subsequent preterm birth.
  
  
  METHODS
  A cohort of 550 women with singleton nonanomalous pregnancies undergoing second-trimester genetic amniocentesis was followed up to delivery and analyzed as a nested case-control study. Cases of preterm birth (n = 52) were compared with 104 term control subjects. Amniotic fluid collected at amniocentesis was tested for TAT.
  
  
  RESULTS
  TAT concentrations were significantly higher in women who delivered preterm (median 115.9 µg/L) than in those who did not (median 62.2 µg/L; P < .001). This difference persisted when 31 spontaneous preterm births and 21 indicated preterm births were analyzed separately. The odds ratios for preterm birth in the highest TAT quartile relative to the lowest quartile was 4.98 (95% confidence interval, 1.17-22.01; P = .007).
  
  
  CONCLUSIONS
  We found a difference in the pattern of intraamniotic thrombin generation between women destined to deliver at term and those who deliver preterm, regardless of the type of preterm birth.
authors.affiliation: Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Texas-Houston Medical School, Houston, TX, USA. vidaeff@bcm.edu
authors.forename: Alex C
authors.initials: AC
authors.lastname: Vidaeff
authors.forename: Manju
authors.initials: M
authors.lastname: Monga
authors.forename: George
authors.initials: G
authors.lastname: Saade
authors.forename: Karen
authors.initials: K
authors.lastname: Bishop
authors.forename: Susan M
authors.initials: SM
authors.lastname: Ramin
mesh_terms: D000328:Adult; D000649:Amniocentesis; D000653:Amniotic Fluid / Q000737:chemistry*; D000990:Antithrombin III / Q000032:analysis / Q000096:biosynthesis*; D016022:Case-Control Studies; D004789:Enzyme Activation; D005260:Female; D006801:Humans; D010447:Peptide Hydrolases / Q000032:analysis / Q000096:biosynthesis*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second / Q000097:blood*; D047928:Premature Birth; D011446:Prospective Studies; D013917:Thrombin / Q000032:analysis / Q000096:biosynthesis*
chemical_list: C046193:antithrombin III-protease complex; D000990:Antithrombin III; D010447:Peptide Hydrolases; D013917:Thrombin